MoviePass competitor Sinemia shuts down operations in the US as ‘Avengers: Endgame’ enters theaters
|04/26/2019||Posted by BusinessMediaguide.Com under General World News||
- MoviePass competitor Sinemia has shut down in the US, the company said on Thursday.
- Sinemia said that its “efforts to cover the cost of unexpected legal proceedings and raise the funds required to continue operations have not been sufficient.”
- The movie-ticket subscription service faced a class-action lawsuit from customers and had promised to give users it had recently terminated partial refunds.
- Visit Business Insider’s homepage for more stories.
Embattled MoviePass competitor Sinemia has shut down its US operations, the company said in a statement posted to its website on Thursday. The abrupt closure came right before “Avengers: Endgame,” which is read more >>>